| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer
|
Madden, Julie M.
|
|
2014
|
147 |
2 |
p. 283-293
|
artikel
|
| 2 |
Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations
|
Maugeri-Saccà, Marcello
|
|
2014
|
147 |
2 |
p. 227-235
|
artikel
|
| 3 |
Assessing response in breast cancer with dynamic contrast-enhanced magnetic resonance imaging: Are signal intensity–time curves adequate?
|
Woolf, David K.
|
|
2014
|
147 |
2 |
p. 335-343
|
artikel
|
| 4 |
Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival
|
Pande, Mala
|
|
2014
|
147 |
2 |
p. 381-387
|
artikel
|
| 5 |
Author’s response to “Letter to the editor: unvalidated antibodies and misleading results”
|
Muenst, S.
|
|
2014
|
147 |
2 |
p. 459-462
|
artikel
|
| 6 |
Circulating tumor cells in non-metastatic triple-negative breast cancer
|
Karhade, Mandar
|
|
2014
|
147 |
2 |
p. 325-333
|
artikel
|
| 7 |
Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy
|
Mimoto, Rei
|
|
2014
|
147 |
2 |
p. 317-324
|
artikel
|
| 8 |
Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer
|
Diaby, Vakaramoko
|
|
2014
|
147 |
2 |
p. 433-441
|
artikel
|
| 9 |
Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program
|
Prummel, Maegan V.
|
|
2014
|
147 |
2 |
p. 389-399
|
artikel
|
| 10 |
Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review
|
Ioannides, S. J.
|
|
2014
|
147 |
2 |
p. 237-248
|
artikel
|
| 11 |
Erratum to: Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer
|
Diaby, Vakaramoko
|
|
2014
|
147 |
2 |
p. 443
|
artikel
|
| 12 |
Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
|
Wei, Yifang
|
|
2014
|
147 |
2 |
p. 423-431
|
artikel
|
| 13 |
High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer
|
Zhang, Cheng
|
|
2014
|
147 |
2 |
p. 265-281
|
artikel
|
| 14 |
Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancer
|
Falato, Claudette
|
|
2014
|
147 |
2 |
p. 407-414
|
artikel
|
| 15 |
Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation
|
Askren, Mary K.
|
|
2014
|
147 |
2 |
p. 445-455
|
artikel
|
| 16 |
Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients
|
Rubio, Isabel T.
|
|
2014
|
147 |
2 |
p. 371-380
|
artikel
|
| 17 |
Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study
|
Allott, E. H.
|
|
2014
|
147 |
2 |
p. 415-421
|
artikel
|
| 18 |
Outcomes of solid palpable masses assessed as BI-RADS 3 or 4A: a retrospective review
|
Patterson, Stephanie K.
|
|
2014
|
147 |
2 |
p. 311-316
|
artikel
|
| 19 |
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
|
Byrski, T.
|
|
2014
|
147 |
2 |
p. 401-405
|
artikel
|
| 20 |
Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer
|
Rudraraju, Bharath
|
|
2014
|
147 |
2 |
p. 295-309
|
artikel
|
| 21 |
Refinement of breast cancer risk prediction with concordant leading edge subsets from prognostic gene signatures
|
Huang, Chi-Cheng
|
|
2014
|
147 |
2 |
p. 353-370
|
artikel
|
| 22 |
Transcriptional repression of ER through hMAPK dependent histone deacetylation by class I HDACs
|
Plotkin, Amy
|
|
2014
|
147 |
2 |
p. 249-263
|
artikel
|
| 23 |
Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer
|
Hartkopf, Andreas D.
|
|
2014
|
147 |
2 |
p. 345-351
|
artikel
|
| 24 |
Unvalidated antibodies and misleading results
|
Rimm, David
|
|
2014
|
147 |
2 |
p. 457-458
|
artikel
|
Tijdschrift beschrijving